Skip to main content
Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
13.31
-1.01 (-7.05%)
At close: Nov 15, 2024, 4:00 PM
13.50
+0.19 (1.43%)
After-hours: Nov 15, 2024, 5:40 PM EST

DAWN Revenue

Day One Biopharmaceuticals had revenue of $93.76M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $101.95M.

Revenue (ttm)
$101.95M
Revenue Growth
n/a
P/S Ratio
11.64
Revenue / Employee
$657,761
Employees
155
Market Cap
1.34B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Guardian Pharmacy Services 1.17B
U.S. Physical Therapy 639.06M
MiMedx Group 342.80M
STAAR Surgical Company 341.22M
Schrödinger 193.35M
Syndax Pharmaceuticals 16.00M
ARS Pharmaceuticals 2.57M
Praxis Precision Medicines 1.61M
Revenue Rankings

DAWN News

More News